SBFC Finance Q1 FY27 Results Analysis: PAT Jumps 29%, GNPA Edges Up

CompoundingAI Research Updated July 26, 2026 2 min read
Neutral

SBFC Finance Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 491.56 Cr (+26.51% YoY) and PAT growth of +28.97% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 25, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 491.56 Cr (+26.51% YoY)
PAT (Q1)Rs. 130.12 Cr (+28.97% YoY)
EPS (Q1)Rs. 1.18 (+26.88% YoY)
Market capRs. 10,207.15 Cr
CMPRs. 92.18

Quarter Snapshot

SBFC reported strong Q1FY27 with 29% PAT growth and 33% NII expansion, driven by loan book growth and effective cost-of-fund management. Cost-to-income improved to 36.35% and capital adequacy remains robust at 31.95%. However, GNPA edged up to 2.66% QoQ and leverage increased, warranting monitoring on asset quality and balance sheet sustainability.

Key Investment Insights

Key Positives

  • Interest income grew 29.50% YoY, NII grew 33.62% YoY, PPOP grew 34.43% YoY
  • Cost-to-income ratio improved to 36.35% from 39.07% YoY
  • PAT grew 28.97% YoY to Rs.130.12 Cr, EPS grew 26.88% YoY to Rs.1.18
  • CRAR at 31.95% remains well above regulatory minimum
  • LCR improved to 216.73% from 145.36% QoQ, indicating strong liquidity
  • Stressed loan recovery rate of 78.98% of NBV from ARC transfers

Risk Factors

  • GNPA rose to 2.66% from 2.61% QoQ, above pre-call expectation range of 1.5-2.0%
  • Impairment on financial instruments increased 67.90% YoY to Rs.41.69 Cr, outpacing revenue growth
  • Operating expenses jumped 16.78% QoQ due to employee costs (+16.60% QoQ) and other expenses (+21.45% QoQ)
  • Debt-equity ratio increased from 1.73x to 2.29x YoY, reflecting rising leverage to fund AUM growth
  • Annualized credit cost estimated at ~1.6% of loan book vs ~1.3% in FY26, indicating higher provisioning
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now